Jameel Dennis is a Senior Scientist at Rivus Pharmaceuticals since March 2019, with a robust background in therapeutic research and development. Prior experience includes a similar role at Gencia Biotechnology from May 2010 to March 2019, focusing on determining the mechanism of action for novel therapeutics. Jameel held Post-Doctoral Fellow positions at Virginia Commonwealth University (June 2004 - April 2010) and Boys Town National Research Hospital (May 2002 - June 2004), engaging in advanced research areas such as oligodendrocyte morphogenesis and renal fibrosis. Academic credentials include a PhD in Neuroscience and a BA in Philosophy, both from the University of Virginia, along with a foundational education at Horace Mann School.